Loading clinical trials...
Loading clinical trials...
Abiraterone Acetate Treatment for Prostate Cancer Patients With a PSA of More Than Four Following Initial Androgen Deprivation Therapy Phase II
Conditions
Interventions
abiraterone acetate
Prednisone
Locations
205
United States
NEA Medical Clinic - East Matthews
Jonesboro, Arkansas, United States
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Highlands Oncology Group - Springdale
Rogers, Arkansas, United States
Kaiser Permanente - Deer Valley
Antioch, California, United States
Kaiser Permanente - Fremont
Fremont, California, United States
Kaiser Permanente Fresno Medical Center
Fresno, California, United States
Start Date
August 9, 2011
Primary Completion Date
November 29, 2016
Completion Date
April 11, 2024
Last Updated
February 26, 2025
NCT06594926
NCT06257264
NCT03620786
NCT04693377
NCT05424783
NCT06334120
Lead Sponsor
SWOG Cancer Research Network
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions